Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

LY3325656

SKU: orb1739475

Description

LY3325656 is a GPR142 agonist with demonstrated anti-diabetic efficacy in preclinical models, showing suitable ADME/PK for human use. It is the first molecule of its class to enter Phase 1 clinical trials for Type 2 diabetes, following studies confirming its in vitro receptor activation and in vivo glucose-lowering effects in animal studies.

Images & Validation

Key Properties

CAS Number1998714-25-2
MW448.44
FormulaC21H23F3N6O2
SMILESCC1=C(N(C)C=N1)C=2NC(=NN2)[C@@H]3C[C@H](N(C(=O)C4=CC(C(F)(F)F)=CC=C4)C)CCO3
TargetOthers

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

25 mg
$ 3,010.00
50 mg
$ 3,720.00
100 mg
$ 4,740.00
DispatchUsually dispatched over 10 weeks
Bulk Enquiry